Co-administration of dexmedetomidine and levobupivacaine results in better onset and duration of epidural anesthesia in lower extremity orthopedic surgery by Zulkifli, H. et al.
ORIGINAL ARTICLE
Bali Journal of Anesthesiology (BJOA) 2019, Volume 3, Number 1: 1-4
E-ISSN: 2549-2276
1Open access: www.bjoa.balijournals.org
CrossMark
Published by DiscoverSys
INTRODUCTION
Surgical procedures of the lower limb area can 
be facilitated by both general and regional anes-
thesia. Regional techniques such as epidural 
anesthesia provide many advantages over general 
anesthesia including maintained patient's aware-
ness, produced adequate analgesia, reduced stress 
response, reduced intraoperative bleeding, reduced 
post-operative pain, earlier mobilization, and 
enhance rehabilitation.1 Drugs that are often used 
in epidural techniques are the amide groups, such 
as bupivacaine, ropivacaine, and levobupivacaine. 
Bupivacaine is a local anesthetic of long-acting 
amide groups that have been used for more than 
40 years. Since its introduction in 1957, this agent 
is associated with a number of side effects such as 
central nervous system and cardiovascular toxicity. 
This leads to further research for a newer and more 
secure local anesthetic agent.2
In recent years, levobupivacaine, the pure 
S (−)-enantiomer of bupivacaine, emerged as a safer 
alternative for regional anesthesia. Levobupivacaine 
pharmacokinetics has been compared with racemic 
bupivacaine in healthy humans, epidural admin-
istration and brachial plexus block with the same 
dose, there is no difference in pharmacokinetic 
parameters between these two agents.3,4 The dura-
tion of analgesic effects of bupivacaine and levobu-
pivacaine was longer than other local anesthetics. 
Both also showed the preferred motor and sensory 
blockade ratio. The enantio-selective properties 
of levobupivacaine exhibit affinity and inhibitory 
forces in the lower cardiac sodium channels as well 
as the blockade effect on cell firing in the central 
nervous system solitary tract nucleus. 
The mean dose of levobupivacaine and bupiva-
caine that cause symptoms of the central nervous 
system in humans are approximately the same 
(56-58 mg for levobupivacaine and 48-65 mg 
for bupivacaine). At this dose, levobupivacaine 
exhibits the depression of myocardial contractility 
and less atrioventricular conduction than bupiv-
acaine. With its advantages in pharmacokinetic 
profile and lack of side effects on the cardiovas-
cular and central nervous system, levobupivacaine 
is an option in regional anesthetics compared to 
bupivacaine.3,4
Although some of the new local anesthetic 
agents above have better safety profiles, these agents 
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ABSTRACT
Background: The goal of this study is to know the efficacy of the 
addition of 0.5 mcg/kg dexmedetomidine to 15 mL isobaric 0.5% 
levobupivacaine on the onset and duration of sensory and motor 
blockade of epidural anesthesia in lower extremity orthopedic surgery.
Methods: Randomized clinical double-blind trials were conducted 
in Dr. Mohammad Hoesin Hospital Palembang. A total of 34 patients 
underwent lower extremity surgery met the inclusion and exclusion 
criteria. Data were analyzed by independent t-test and Mann-Whitney 
test using SPSS 22.0 software.
Result: The onset of sensory block in group D was 5.41±1.84 minutes 
compared to 17.59± 2.65 in Group C (p <0.001), as seen in Table 2. 
The sensory block duration was 362.41±25.66 minutes in Group  D 
compared to 215.82±15.69 in Group C (p <0.001). The onset of 
the motoric block in group D was 16.53±1.81 minutes compared to 
26.12±2.78 in Group C (p <0.001), while the motoric block duration 
was 301.29±20.55 minutes in Group D compared to 167.35±17.24 in 
Group C (p <0.001).
Conclusion: The addition of 0.5mcg/kg dexmedetomidine to 15 ml 
isobaric 0.5% levobupivacaine in epidural anesthesia provide faster 
onset and prolonged duration in both motoric and sensory block in 
patients undergoing lower extremity surgery.
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still have a long-term onset of work and limited 
duration. Burlacu et al.4 reported the average onset 
of sensory blockade was 8-30 minutes in 4-6 hours 
duration. To fasten the onset, the addition of other 
drugs (adjuvant) to local anesthetics is commonly 
practiced. These adjuvants include opioid, neostig-
mine, clonidine, and dexmedetomidine.5,6
Dexmedetomidine, an α2-adrenergic agonist 
group, was first introduced by the Food and Drug 
Administration (FDA) in 1999. Dexmedetomidine 
has antinociceptive effects that reduce hyperalgesia, 
prevent catecholamine release, and used as a seda-
tive during surgery and postoperative periods.6
Schanabel et al.6 showed that 1-2 mcg/kg dexme-
detomidine as adjuvant local anesthesia in epidural 
anesthesia may accelerate the onset of the sensory 
blockade and increase the duration of sensory and 
motor blockade with no respiratory depression effect.
The effect of dexmedetomidine administration as 
adjuvant for regional anesthesia in both spinal and 
epidural anesthesia is potential to accelerate the onset 
of sensory blockade, prolong the duration of sensory 
and motor blockade, sedation effects, prolong post-
operative analgesic administration, decrease the side 
effects of nausea and vomiting, no respiratory depres-
sion but bradycardia and hypotension can occur.7-13
PATIENTS AND METHODS
This study is a double-blind, randomized controlled 
trial. The study was conducted in the operat-
ing room of Dr. Mohammad Hoesin Hospital 
(Palembang, Indonesia) from January to April 
2017. The study population is patients underwent 
lower limb orthopedic surgery in Dr. Mohammad 
Hoesin Hospital under epidural anesthesia. The 
study protocol was approved by the hospital’s ethics 
committee. All involved subjects provided written 
informed consent to be included in this study.
The inclusion criteria were ASA (American 
Society of Anesthesiologist) I-II patient, aged 
17-60  years, and scheduled for lower extremity 
surgery. Exclusion criteria were pregnancy, unsuit-
able condition for epidural anesthesia, and those 
who received sedative or analgesic medications 
24 hours prior to surgery. Those who experienced 
epidural block failure after 30 minutes of epidural 
injection were excluded from the study.
The subjects were divided randomly into two 
groups. Group D received 0.5 μg/kg dexmedetomi-
dine and 15 mL 0.5% levobupivacaine by epidural 
injection, and Group C received 15 mL 0.5% 
levobupivacaine + 1 mL 0.9% NaCl. The injection 
formula was put into the same 20 mL syringe so that 
the anesthetist performed the injection would not 
have known the exact composition. All other drugs 
and procedures were the same to both groups. 
Pinprick test was used to assess the sensory 
block. Motor blockade was assessed using the 
Bromage scale. Systolic blood pressure, diastolic 
blood pressure, and pulse rate were assessed 
every 5 minutes after injection for 60 minutes and 
thereafter every 10 minutes during surgery with a 
Spacelabs monitor, model No. 91369. 
Data were analyzed using SPSS 22.0 software. 
Descriptive analysis was used in the subject’s 
characteristic. Shapiro-Wilk test was used in the 
normality test. Mann-Whitney test and inde-
pendent t-test were used to compare the data 
between groups. A p-value of <0.05 was consid-
ered significant. 
RESULTS
A total of 34 patients were enrolled in this study, 
divided into two study groups consist of 17 subjects 
each. General characteristics of research subjects 
are shown in table 1. The mean age in Group D 
Table 1 Characteristics of the subjects
Characteristics
Groups
D C
Age (year), mean±SD 34.00 ± 15.6 31.65 ± 14.03
Weight (kg), mean±SD 59.53 ± 9.06 56.59 ± 9.16
Height (cm), mean±SD 160.65 ± 7.43 160.53 ± 9.12
Duration of surgery (minute), mean±SD 172.77 ± 54.51 141.72 ± 29.75
Sex, n (%)
•  Male 9 (52.9) 9 (52.9)
•  Female 8 (47.1) 8 (47.1)
ASA n (%)
•  I 11 (64.7) 14 (82.4)
•  II 6 (35.3) 3 (17.6)
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was 34.00±15.6 years and in Group C was 31.65 ± 
14.03 years. Normality test results showed that all 
data were normally distributed and comparable.
The onset of sensory block in group D was 
5.41±1.84 minutes compared to 17.59± 2.65 in 
Group C (p <0.001), as seen in Table 2. The sensory 
block duration was 362.41±25.66 minutes in Group 
D compared to 215.82±15.69 in Group C (p <0.001). 
The onset of the motoric block in group  D was 
16.53±1.81 minutes compared to 26.12±2.78 in 
Group C (p <0.001), while the motoric block 
duration was 301.29±20.55 minutes in Group D 
compared to 167.35±17.24 in Group C (p <0.001).
DISCUSSION
This study found significant differences in onset and 
duration of both motoric and sensory blockade in 
epidural anesthesia between the two groups. These 
results were similar to the one reported by Bajwa 
et al13 that found significant differences in sensory 
blockade onset, duration of sensory blockade and 
regression of two segments between groups given 
1.5 μg/kg dexmedetomidine and 2 μg/kg clonidine. 
In this study, however, the onset of sensory blockade 
was faster (5.41±1.84 minutes) than in the Bajwa 
study (8.52±2.36 minutes). Likewise, the mean time 
of regression of two segments and the duration 
of the sensory blockade where the mean time of 
regression of two segments of the results obtained in 
the Bajwa study was shorter (136.46±8.12 minutes) 
than in this study (226.12±20.45 minutes) and the 
duration of the sensory blockade in the Bajwa study 
was shorter (342.88±29.16 minutes) than in this 
study (362.41±25.66 minutes).
This study also found similar results to Kaur 
et  al7 that reported significantly faster onset and 
longer duration of the motor blockade in subjects 
who were given 1 μg/kg dexmedetomidine. This 
study found a faster onset of the motor blockade 
(16.53±1.81 minutes) than the Kaur study (27.34 ± 
5.97 minutes). The duration of the motor blockades 
in this study was longer (301.29 ± 20.55 min) than 
in the Kaur study (259.8 ± 15.49 min).
Dexmedetomidine is highly lipophilic, making it 
easier and faster to bind to a spinal cord that has the 
potential to affect local anesthesia.13-16 The mecha-
nism of dexmedetomidine binds to α2 receptors in 
the dorsal horn pre and post-synapse of the spinal 
cord lowers the stimulus of nociceptive substance 
in neuraxial use.6,13,17-23
Dexmedetomidine acts on the α2 adrenocep-
tor in the core and spinal cord locus. The mech-
anism of the presynapse is at the α2C and α2A 
receptors dorsal horn neurons which inhibits 
transmitter release of substance P and glutamate, 
and hyperpolarization of spinal interneuron-me-
diated through G protein produces a synergistic 
analgesia effect with local anesthetic agents.24-26 
This leads to an elongation of the duration of 
the sensory blockade. While on postsynapse, 
the mechanism of dexmedetomidine through 
α2B which produces vasoconstriction effect at 
the injection site thus slowing the absorption of 
local anesthesia.27-28 This mechanism resulted in 
the prolongation of sensory and motor blockade 
of epidural anesthesia. The mechanism of action 
of analgesia from both α2 adrenergic agonist 
spinal and supraspinal is that modulate nocicep-
tive transmission in the central nervous system, 
although α2 receptors in the periphery may also 
mediate antinociceptive.5,6,13,29-32
CONCLUSION
The addition of 0.5mcg/kg dexmedetomidine to 
15 ml isobaric 0.5% levobupivacaine in epidural 
anesthesia provide faster onset and prolonged dura-
tion in both motoric and sensory block in patients 
undergoing lower extremity surgery.
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